Icon PLC (ICLR): Total Assets

Annual figures by period end, from SEC filings.

$16.27B
As of 2025-12-31
-1.8%
3-year compound annual growth
+36.5%
5-year compound annual growth
+25.2%
10-year compound annual growth
$17.39B2009-12-31: $908.40M2010-12-31: $949.54M2011-12-31: $1.03B2012-12-31: $1.20B2013-12-31: $1.44B2014-12-31: $1.53B2015-12-31: $1.72B2016-12-31: $1.83B2017-12-31: $2.15B2018-12-31: $2.35B2019-12-31: $2.91B2020-12-31: $3.44B2021-12-31: $17.39B2022-12-31: $17.19B2023-12-31: $16.86B2024-12-31: $16.63B2025-12-31: $16.27B$16.27B
2009-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$16.27B-2.2%2026-05-27, Balance as of period end
2024-12-31$16.63B-1.4%2026-05-27, Balance as of period end
2023-12-31$16.86B-1.9%2026-05-27, Balance as of period end
2022-12-31$17.19B-1.2%2024-02-23, Balance as of period end
2021-12-31$17.39B+406.1%2023-02-24, Balance as of period end
2020-12-31$3.44B+18.2%2022-03-01, Balance as of period end
2019-12-31$2.91B+23.5%2021-02-24, Balance as of period end
2018-12-31$2.35B+9.7%2020-02-27, Balance as of period end
2017-12-31$2.15B+17.6%2019-03-01, Balance as of period end
2016-12-31$1.83B+6.3%2018-02-28, Balance as of period end
2015-12-31$1.72B+12.3%2017-02-28, Balance as of period end
2014-12-31$1.53B+6.0%2016-03-23, Balance as of period end
2013-12-31$1.44B+20.0%2015-03-12, Balance as of period end
2012-12-31$1.20B+17.0%2014-03-12, Balance as of period end
2011-12-31$1.03B+8.2%2013-03-06, Balance as of period end
2010-12-31$949.54M+4.5%2012-03-02, Balance as of period end
2009-12-31$908.40Mn/a2011-03-22, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Icon PLC (ICLR)2025-12-31$16.27B-2.2%
Incyte Corp (INCY)2025-12-31$6.96B+27.8%
Iqvia Holdings Inc. (IQV)2025-12-31$29.94B+11.3%
Charles River Laboratories International, Inc. (CRL)2025-12-27$7.14B-5.2%
Medpace Holdings, Inc. (MEDP)2025-12-31$1.98B-6.0%
NRC Health (NRC)2025-12-31$134.88M+1.8%
MaxCyte, Inc. (MXCT)2025-12-31$202.51M-15.4%
OmniAb, Inc. (OABI)2025-12-31$300.91M-7.6%
Foxo Technologies Inc. (FOXO)2025-12-31$44.58M+6.9%

Compare ICLR, INCY, IQV, CRL side by side · Screen every company in Services-Commercial Physical & Biological Research ↗